Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic
Stage Ia Breast Cancer
15
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT03407716
Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors
Completed · Early_Phase 1
NCT00407888
Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery
Completed · Phase 2
NCT00513292
Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
Completed · Phase 3
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Stage Ia Breast Cancer
🏥 Names
Disease Name
Stage Ia Breast Cancer
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
🔗 External References
HERB DB
DisGeNET
C4724023
🔍 Raw view — every non-empty column on this row (19 fields)
name
Stage Ia Breast Cancer
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
umls disease type id
T191
herb disease id
HBDIS027840
disgenet id
C4724023
🌿 Related Herbs
1 · shared evidence⚗️ Related Ingredients
1 · shared evidence📋 Clinical Trials
12 · subject of clinical studyNCT03407716 Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors
→ Cancer Survivor|Stage I Breast Cancer AJCC v7|Stag
NCT00407888 Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitax
→ Estrogen Receptor-positive Breast Cancer|HER2-posi
NCT00513292 Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With
→ HER2/Neu Positive|Stage IA Breast Cancer|Stage IB
NCT01106898 Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast
→ Stage IA Breast Cancer|Stage IB Breast Cancer|Stag
NCT01750073 Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Trea
→ Estrogen Receptor Negative|Estrogen Receptor Posit
NCT02654119 Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Po
→ HER2 Positive Breast Carcinoma|Stage I Breast Canc
NCT02689427 Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III
→ Invasive Breast Carcinoma|Stage I Breast Cancer AJ
NCT04001829 Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients Wit
→ Anatomic Stage I Breast Cancer AJCC v8|Anatomic St
NCT04862585 Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving
→ Anatomic Stage 0 Breast Cancer AJCC v8|Anatomic St
NCT00005970 Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trast
→ Breast Adenocarcinoma|HER2 Positive Breast Carcino
NCT00194779 Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With
→ Estrogen Receptor-negative Breast Cancer|Estrogen
NCT00618657 Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in t
→ Breast Cancer|HER2-negative Breast Cancer|HER2-pos
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
empty — needs
HERB_herb_ingredientimport - Ingredient ↔ Target:
empty — needs
HERB_ingredient_targetimport - Target ↔ Disease:
empty — needs
HERB_target_diseaseimport - Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables